Mubritinib
| CAS No. | 366017-09-6 |
|---|---|
| MDL No. | MFCD09954135 |
| MF | C25H23F3N4O2 |
| MW | 468.50 |
| InChI Key | ZTFBIUXIQYRUNT-MDWZMJQESA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Mubritinib has been studied in trials for the treatment of Lung Neoplasm, Renal Neoplasm, Breast Neoplasm, Ovarian Neoplasm, and Pancreatic Neoplasm.
| CAS No. | 366017-09-6 |
|---|---|
| Product Name | Mubritinib |
Biological Targets
ERBB2
Associated Conditions
pancreatic neoplasm·ovarian neoplasm·kidney neoplasm·lung neoplasm·breast neoplasm
* The information provided here is compiled from public sources and is for reference only.